bioAffinity Technologies, Inc. — Form 8-K
Filed September 11, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
bioAffinity Technologies filed a Form 8-K on 2026-09-11 under Items 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits). The filing consists primarily of graphics and XBRL data files with no accessible textual description of any specific corporate event, transaction, counterparty, dollar amount, or date-specific development. The actual substance of the disclosure is not visible in the filing index provided.
Why this rating
Cannot assess materiality without access to actual disclosure content. Index shows only file structure, not event details. Filing is routine administrative submission.
Extracted items
- 7.01 Reg FD disclosure
- 9.01 exhibits
See more from September 11, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.